Moors & Cabot Inc. Makes New Investment in Grail, Inc. (NASDAQ:GRAL)

Moors & Cabot Inc. acquired a new position in Grail, Inc. (NASDAQ:GRAL) in the 4th quarter, Holdings Channel reports. The institutional investor acquired 13,680 shares of the company’s stock, valued at approximately $244,000.

Several other large investors also recently modified their holdings of the company. Wealthfront Advisers LLC bought a new stake in shares of Grail in the fourth quarter worth $100,000. Crcm LP bought a new stake in shares of Grail in the fourth quarter worth $65,061,000. Jackson Hole Capital Partners LLC bought a new stake in shares of Grail in the fourth quarter worth $589,000. Burren Capital Advisors Ltd bought a new stake in shares of Grail in the fourth quarter worth $220,000. Finally, PNC Financial Services Group Inc. bought a new stake in shares of Grail in the fourth quarter worth $86,000.

Insider Activity at Grail

In other news, CFO Aaron Freidin sold 1,816 shares of the business’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $56,659.20. Following the transaction, the chief financial officer now directly owns 335,170 shares in the company, valued at $10,457,304. The trade was a 0.54 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Robert P. Ragusa sold 7,625 shares of the business’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $31.21, for a total value of $237,976.25. Following the completion of the transaction, the chief executive officer now owns 828,662 shares in the company, valued at $25,862,541.02. The trade was a 0.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 11,550 shares of company stock worth $360,436.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley assumed coverage on Grail in a report on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 price objective for the company.

Grail Trading Up 10.5 %

NASDAQ GRAL opened at $29.74 on Monday. The business’s fifty day moving average is $31.81 and its 200 day moving average is $21.39. Grail, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $63.99.

Grail (NASDAQ:GRAL) last released its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, beating the consensus estimate of ($4.41) by $2.55. The company had revenue of $38.25 million for the quarter, compared to analysts’ expectations of $35.33 million. As a group, equities research analysts predict that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.